Evidence map›Paper›PMID 40348925›Full record

ArticleScientific reports2025

STAT3-mediated upregulation of TRIM6 promotes hepatocellular carcinoma invasion through the DDX58-Snail1 axis.

Yiqiao Wang, Jie Wang, Shihao Huang, Xingjing Liu, Yangbai Cai, Taicheng Wang, Hongyan Zhao, Xianke Lin, Xueguo Wang, Peng Li

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yiqiao Wang *Department of Hepatobiliary and Pancreatic Surgery, Yueqing Hospital Affiliated to Wenzhou Medical University, Yueqing, 325600, Zhejiang Province, China.
Jie Wang *Department of Traditional Chinese Medicine, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Shihao HuangDepartment of Hepatobiliary and Pancreatic Surgery, Yueqing Hospital Affiliated to Wenzhou Medical University, Yueqing, 325600, Zhejiang Province, China.
Xingjing LiuDepartment of Traditional Chinese Medicine, North Hospital of Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 201800, China.
Yangbai CaiDepartment of Hepatobiliary and Pancreatic Surgery, The Second Affiliated Hospital of Hainan Medical University, Haikou, 570100, China.
Taicheng WangDepartment of Hepatobiliary and Pancreatic Surgery, The Second Affiliated Hospital of Hainan Medical University, Haikou, 570100, China.
Hongyan ZhaoDepartment of Hepatobiliary and Pancreatic Surgery, The Second Affiliated Hospital of Hainan Medical University, Haikou, 570100, China.
Xianke LinDepartment of Hepatobiliary and Pancreatic Surgery, The Second Affiliated Hospital of Hainan Medical University, Haikou, 570100, China.
Xueguo WangDepartment of Hepatobiliary and Pancreatic Surgery, The Second Affiliated Hospital of Hainan Medical University, Haikou, 570100, China.
Peng LiDepartment of Hepatobiliary and Pancreatic Surgery, The Second Affiliated Hospital of Hainan Medical University, Haikou, 570100, China. lipeng@hainmc.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatocellular carcinoma (HCC) is a highly aggressive malignancy with poor prognosis, driven by complex molecular mechanisms that remain inadequately understood. Among these, the ubiquitin-proteasome system plays a crucial role in regulating protein stability and function, with E3 ubiquitin ligases emerging as key players in cancer progression. Here, we identify Tripartite Motif-containing 6 (TRIM6), an E3 ubiquitin ligase, as a critical regulator of HCC metastasis. We demonstrate that TRIM6 is significantly upregulated in HCC tissues and correlates with poor overall survival. Mechanistically, we uncover that STAT3 directly regulates TRIM6 by binding to its promoter and enhancing its transcription. Functionally, TRIM6 promotes epithelial-mesenchymal transition (EMT) and cell invasion by upregulating the key EMT transcription factor Snail1. Importantly, we reveal that TRIM6 interacts with and ubiquitinates DDX58 (RIG-I), leading to its proteasomal degradation. The degradation of DDX58 by TRIM6 alleviates its inhibitory effects on Snail1, thereby facilitating EMT and enhancing the invasive potential of HCC cells. These findings establish the STAT3-TRIM6-DDX58-Snail1 axis as a pivotal pathway in HCC progression, offering novel insights into the molecular underpinnings of HCC metastasis and highlighting TRIM6 as a potential therapeutic target and prognostic biomarker in HCC.

Indexed as

Carcinoma, HepatocellularDEAD-box RNA HelicasesLiver NeoplasmsSnail Family Transcription FactorsSTAT3 Transcription FactorTripartite Motif ProteinsUbiquitin-Protein LigasesAnimalsCell Line, TumorCell MovementEpithelial-Mesenchymal TransitionFemaleGene Expression Regulation, NeoplasticHumansMaleMiceDEAD-box RNA HelicasesSNAI1 protein, humanSnail Family Transcription FactorsSTAT3 protein, humanSTAT3 Transcription FactorTripartite Motif ProteinsUbiquitin-Protein LigasesDDX58E3 ubiquitin ligaseEpithelial-mesenchymal transition (EMT)Hepatocellular carcinomaMetastasisSTAT3TRIM6

Identifiers

PMID40348925
PMCPMC12065863

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.